All-trans-retinoic acid-induced myositis: A description of two patients

American Journal of Hematology

Volumn 63, Issue 2, 2000, Pages 94-98

  Van Der Vliet, Hans J J ^a,b   Roberson, Arthur E ^a   Hogan, Marie C ^a   Morales, Carlos E ^a   Crader, Scott C ^a   Letendre, Louis ^a   Pruthi, Rajiv K ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute; Leukemia; Myositis; Promyelocytic; Retinoic acid; Sweet's syndrome; Tretinoin

Indexed keywords

RETINOIC ACID;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; FEMALE; FEVER; HUMAN; MALE; MYALGIA; MYOSITIS; PRIORITY JOURNAL; REMISSION;

ADULT; DEXAMETHASONE; FEMALE; FEVER; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MYOSITIS; SWEET'S SYNDROME; TRETINOIN;

EID: 0033973278     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200002)63:2<94::AID-AJH7>3.0.CO;2-H     Document Type: Article

References (27)

1. Stone RM, Mayer RJ. The unique aspects of acute promyelocytic leukemia. J Clin Oncol 1990;8:1913.
2. Mayer RJ, Schiffer CA, Peterson BA, Budman DR, Silver RT, Rai KR, Cornwell GG, Ellison RR, Maguire M, Berg DT, Davis RB, McIntyre OR, Frei E. III. Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: A progress report from the CALGB. Cancer and Leukemia Group B. Semin Oncol 1987;14(Suppl 1):25.
3. Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 1984;76:827.
4. Chomienne C, Ballerini P, Balitrand N, Huang ME, Krawice I, Castaigne S, Fenaux P, Tiollais P, Dejean A, Degos L, de The H. The retinoic acid receptor α gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 1990;4:802.
5. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR α with a novel putative transcription factor, PML. Cell 1991;66:663.
6. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567.
7. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704.
8. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324:1385.
9. Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrovsky E, Warrell RP Jr. All-trans-retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Ann Intern Med 1994;120:278.
10. Frankel S, Weiss M, Warrell RP Jr. A "retinoic acid syndrome" in acute promyelocytic leukemia: Reversal by corticosteroids. Blood 1991;78(Suppl):380a.
11. Tomas JF, Escudero A, Fernandez-Ranada JM. All-trans retinoic acid treatment and Sweet syndrome (letter). Leukemia 1994;8:1596.
12. Piette WW, Trapp JF, O'Donnell MJ, Argenyi Z, Talbot EA, Burns CP. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 1994;30:293.
13. Cox NH, O'Brien HA. Sweet's syndrome associated with trans retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 1994;19:51.
14. Christ E, Linka A, Jacky E, Speich R, Marincek B, Schaffner A. Sweet's syndrome involving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans-retinoic acid. Leukemia 1996;10:731.
15. Arun B, Berberian B, Azumi N, Frankel SR, Luksenburg H, Freter C. Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia. Leuk Lymphoma 1998;31: 613.
16. Warrell RP Jr, de The H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993;329:177.
17. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349.
18. Sweet RD. Acute febrile neutrophilic dermatosis - 1978. Br J Dermatol 1979;100:93.
19. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: Review of the world literature. J Clin Oncol 1988;6:1887.
20. von den Driesch P. Sweet's syndrome. J Am Acad Dermatol 1994;31: 535.
21. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: Review of the world literature. J Clin Oncol 1988;6:1887.
22. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. all-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704.
23. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 1992;117:292.
24. Reuss-Borst MA, Muller CA, Waller HD. The possible role of G-CSF in the pathogenesis of Sweet's syndrome. Leuk Lymphoma 1994;15: 261.
25. Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 1992;116:996.
26. Eghrari-Sabet JS, Hartley AH. Sweet's syndrome: An immunologically mediated skin disease? Ann Allergy 1994;72:125.
27. Larson RS, Brown DC, Sklar LA. Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood 1997;90:2747.